ERBB2 and cancer: CAR NK cells are constructed by genetic modification of NK cells from different sources, including hematopoietic pluripotent stem cells (HPSCs), primary NK cells, as well as NK cell lines, to express CARs in order to enhance the recognition of a particular surface marker of cancer cells such as CD19, CD20, and ErbB2.